Vote Scores

Home / Companies / Revolution Medicines, Inc. / 8 Nov 2023

Meeting · year to 30 June 2024123 filers reporting

Revolution Medicines, Inc.: meeting of 8 Nov 2023

Votes reported on Form N-PX, item by item

123 Form N-PX filers reported votes at the Revolution Medicines, Inc. meeting of 8 Nov 2023. Their records fall into 2 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

EXTRAORDINARY TRANSACTIONSIssuer

EXTRAORDINARY TRANSACTIONS: management items

Management items in this category are shown together; filers word and number them differently.

193 vote records from 109 filers. 10 of the 108 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

89.0% for11.0% against9.3% against management109 filers79.9% for19.8% against0.3% other19.8% against management33,844,626 reported shares, counted once per item in this group
2

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

249 vote records from 123 filers. 19 of the 122 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.

82.1% for14.6% against3.3% other15.6% against management123 filers79.2% for20.5% against0.3% other20.8% against management38,831,726 reported shares, counted once per item in this group

How the largest families voted

None of the families tracked on this site reported a position on these items.

Questions

How did large funds vote at the Revolution Medicines, Inc. meeting?

123 Form N-PX filers reported votes at the meeting of 8 Nov 2023. The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Revolution Medicines, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Revolution Medicines, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Revolution Medicines, Inc. with a meeting date within three days of 8 Nov 2023. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.